Opis działalności
Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
Zarząd & Rada nadzorcza
| CEO |
| Adam Schechter |
| Zarząd |
| Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson |
| Rada nadzorcza |
| Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D. |
Dane firmy
| Nazwa: |
Laboratory Corporation of America Holdings |
| Adres: |
531 South Spring Street,Burlington, North Carolina 27215, USA |
| Telefon: |
+1-336-229-1127 |
| Fax: |
+1-336-436-1569 |
| E-mail: |
-
|
| Internet: |
https://www.labcorp.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
Zaawansowane Urządzenia Medyczne |
| Koniec roku finansowego: |
31.12 |
| Free float: |
78,40% |
| Data IPO: |
- |
Relacje inwestorskie
| Nazwa: |
Chas Cook |
| Telefon: |
+1-336-436-5076 |
| Fax: |
336-436-1569 |
| E-mail: |
investor@labcorp.com
|
